Download Files:
Products Details
Product Description
– Cefilavancin (TD-1792) is a potent multivalent glycopeptide-cephalosporin heterodimer antibiotic with effective activity against Gram-positive bacteria. Cefilavancin has been used to research skin infections[1][2][3].
Web ID
– HY-19466
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C87H95Cl3N16O28S2
References
– [1]Blais J, et al. Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic. Antimicrob Agents Chemother. 2012 Mar;56(3):1584-7.|[2]Stryjewski ME, et al. TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections. Antimicrob Agents Chemother. 2012 Nov;56(11):5476-83.|[3]Hegde SS, et al. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model. Antimicrob Agents Chemother. 2012 Mar;56(3):1578-83.
CAS Number
– 1393900-12-3
Molecular Weight
– 1983.26
SMILES
– [O-]C(C1=C(C[N+]2=CC=CC=C2)CS[C@@]([C@@H]3NC(/C(C4=C(SC(N)=N4)Cl)=NOCCCNC([C@@H]5C6=CC(O)=CC(O)=C6C7=CC([C@]8([H])C(N[C@]([C@@H](C9=CC=C(OC%10=CC([C@](NC([C@@H](NC([C@@H]([C@@H](C%11=CC=C(O%12)C(Cl)=C%11)O)NC([C@H](NC)CC(C)C)=O)=O)CC(N)=O)=O)([H])C(N8)=O)=CC%12=C%10O[C@H]%13[C@@H]([C@H]([C@@H]([C@H](O%13)CO)O)O)O[C@H]%14C[C@](N)([C@@H]([C@@H](O%14)C)O)C)C(Cl)=C9)O)([H])C(N5)=O)=O)=CC=C7O)=O)=O)([H])N1C3=O)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Antibiotic;Bacterial
Isoform
– Glycopeptide
Pathway
– Anti-infection
Product type
– Peptides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
